These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 34204170)

  • 21. Chlamydia trachomatis: impact on human reproduction.
    Paavonen J; Eggert-Kruse W
    Hum Reprod Update; 1999; 5(5):433-47. PubMed ID: 10582782
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ophthalmia neonatorum in a trachoma endemic area.
    Datta P; Frost E; Peeling R; Masinde S; Deslandes S; Echelu C; Wamola I; Brunham RC
    Sex Transm Dis; 1994; 21(1):1-4. PubMed ID: 8140482
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intramuscular Immunisation with Chlamydial Proteins Induces Chlamydia trachomatis Specific Ocular Antibodies.
    Badamchi-Zadeh A; McKay PF; Holland MJ; Paes W; Brzozowski A; Lacey C; Follmann F; Tregoning JS; Shattock RJ
    PLoS One; 2015; 10(10):e0141209. PubMed ID: 26501198
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of Murine Cervicovaginal Infection by Chlamydial Strains: Identification of Extrusions Shed
    Shaw JH; Behar AR; Snider TA; Allen NA; Lutter EI
    Front Cell Infect Microbiol; 2017; 7():18. PubMed ID: 28217555
    [No Abstract]   [Full Text] [Related]  

  • 25. Plasmid Negative Regulation of CPAF Expression Is Pgp4 Independent and Restricted to Invasive
    Patton MJ; Chen CY; Yang C; McCorrister S; Grant C; Westmacott G; Yuan XY; Ochoa E; Fariss R; Whitmire WM; Carlson JH; Caldwell HD; McClarty G
    mBio; 2018 Jan; 9(1):. PubMed ID: 29382731
    [No Abstract]   [Full Text] [Related]  

  • 26. Comparison of Chlamydia outer membrane complex to recombinant outer membrane proteins as vaccine.
    Yu H; Karunakaran KP; Jiang X; Chan Q; Rose C; Foster LJ; Johnson RM; Brunham RC
    Vaccine; 2020 Apr; 38(16):3280-3291. PubMed ID: 32151463
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Outer membrane proteins preferentially load MHC class II peptides: implications for a Chlamydia trachomatis T cell vaccine.
    Karunakaran KP; Yu H; Jiang X; Chan Q; Moon KM; Foster LJ; Brunham RC
    Vaccine; 2015 Apr; 33(18):2159-66. PubMed ID: 25738816
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A multi-subunit Chlamydia vaccine inducing neutralizing antibodies and strong IFN-γ⁺ CMI responses protects against a genital infection in minipigs.
    Bøje S; Olsen AW; Erneholm K; Agerholm JS; Jungersen G; Andersen P; Follmann F
    Immunol Cell Biol; 2016 Feb; 94(2):185-95. PubMed ID: 26268662
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epidemiology of sexually transmitted Chlamydia trachomatis infections.
    Thompson SE; Washington AE
    Epidemiol Rev; 1983; 5():96-123. PubMed ID: 6357824
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical Persistence of Chlamydia trachomatis Sexually Transmitted Strains Involves Novel Mutations in the Functional αββα Tetramer of the Tryptophan Synthase Operon.
    Somboonna N; Ziklo N; Ferrin TE; Hyuk Suh J; Dean D
    mBio; 2019 Jul; 10(4):. PubMed ID: 31311884
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Overview of Chlamydia trachomatis infection and the requirements for a vaccine.
    Schachter J
    Rev Infect Dis; 1985; 7(6):713-6. PubMed ID: 3840910
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A chlamydial major outer membrane protein extract as a trachoma vaccine candidate.
    Campos M; Pal S; O'Brien TP; Taylor HR; Prendergast RA; Whittum-Hudson JA
    Invest Ophthalmol Vis Sci; 1995 Jul; 36(8):1477-91. PubMed ID: 7601629
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interpretation of Chlamydia trachomatis antibody response in chlamydial oculogenital infection.
    Patel HC; Goh BT; Viswalingam ND; Treharne JD
    Genitourin Med; 1995 Apr; 71(2):94-7. PubMed ID: 7744422
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vaccination with the polymorphic membrane protein A reduces Chlamydia muridarum induced genital tract pathology.
    Müller T; Becker E; Stallmann S; Waldhuber A; Römmler-Dreher F; Albrecht S; Mohr F; Hegemann JH; Miethke T
    Vaccine; 2017 May; 35(21):2801-2810. PubMed ID: 28413133
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chlamydia trachomatis, infertility, and population growth in sub-Saharan Africa.
    Brunham RC; Cheang M; McMaster J; Garnett G; Anderson R
    Sex Transm Dis; 1993; 20(3):168-73. PubMed ID: 8511712
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Induction of HLA class I-restricted CD8+ CTLs specific for the major outer membrane protein of Chlamydia trachomatis in human genital tract infections.
    Kim SK; Angevine M; Demick K; Ortiz L; Rudersdorf R; Watkins D; DeMars R
    J Immunol; 1999 Jun; 162(11):6855-66. PubMed ID: 10352308
    [TBL] [Abstract][Full Text] [Related]  

  • 37.
    Shillova N; Howe SE; Hyseni B; Ridgell D; Fisher DJ; Konjufca V
    Infect Immun; 2020 Dec; 89(1):. PubMed ID: 33139380
    [No Abstract]   [Full Text] [Related]  

  • 38. Selected Immunological Mediators and Cervical Microbial Signatures in Women with Chlamydia trachomatis Infection.
    Filardo S; Di Pietro M; Tranquilli G; Latino MA; Recine N; Porpora MG; Sessa R
    mSystems; 2019 Jun; 4(4):. PubMed ID: 31164450
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Spectroscopic analysis of chlamydial major outer membrane protein in support of structure elucidation.
    Hepler RW; Nahas DD; Lucas B; Kaufhold R; Flynn JA; Galli JD; Swoyer R; Wagner JM; Espeseth AS; Joyce JG; Cook JC; Durr E
    Protein Sci; 2018 Nov; 27(11):1923-1941. PubMed ID: 30144190
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acquired homotypic and heterotypic immunity against oculogenital Chlamydia trachomatis serovars following female genital tract infection in mice.
    Lyons JM; Morré SA; Airo-Brown LP; Peña AS; Ito JI
    BMC Infect Dis; 2005 Nov; 5():105. PubMed ID: 16293190
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.